News & Stories
Partners In Health (PIH) Lesotho is changing the story through its TB Elimination Project, a bold, community-centered approach that takes screening, diagnosis, and care directly to the people most at risk.
In 2022, Qabane was diagnosed with multidrug-resistant tuberculosis (MDR-TB) at Partners In Health (PIH)-supported Nkau Health Center and immediately began treatment, which includes medication and social support, such as food and transportation.
Through the OVC program, Mankopane and her brother received mental health support, including therapy sessions. Other support included school fees and supplies, food, clothes, and medical care.
Mahapa, who grew up in rural Lesotho, was diagnosed with HIV in 2019. Two years later, he contracted tuberculosis.
Nthabiseng Mokone, a 27-year-old patient with multidrug-resistant tuberculosis (MDR-TB). After spending six months in inpatient care, Mokone recently reunited with her loved ones.
Less than a decade ago, most expectant mothers in Lesotho didn’t have the option to give birth at a health center. Instead, they delivered at home often without the help of health care workers.
Partners In Health (PIH) welcomes the news that Danaher Corporation will lower the price of its high-quality tuberculosis test cartridge, the Xpert MTB/RIF Ultra, by 20 percent and urges the Washington, DC-based conglomerate to do more.
Globally, tuberculosis [TB] cases and deaths spiked during the COVID-19 pandemic as health systems and medical workers diverted their attention to cope with unprecedented demand for care and treatment for the rapidly spreading infectious disease.